Id: | acc1735 |
Group: | 2sens |
Protein: | BAD |
Gene Symbol: | BAD |
Protein Id: | P50408 |
Protein Name: | VATF_RAT |
PTM: | phosphorylation |
Site: | Ser136 |
Site Sequence: | ---------------------------- |
Disease Category: | Cancer |
Disease: | Osteosarcoma |
Disease Subtype: | |
Disease Cellline: | |
Disease Info: | |
Drug: | quercetin(QUE) |
Drug Info: | "Quercetin (QUE) is a naturally occurring flavonoid with antioxidant, anti-inflammatory, and potential anticancer properties, commonly found in various fruits, vegetables, and grains, and used as a dietary supplement for its purported health benefits." |
Effect: | modulate |
Effect Info: | "100 μM quercetin decreased the phosphorylation levels of AKT and BAD and increased the phosphorylation of ERK1/2, leading to the death of osteosarcoma cells." |
Note: | |
Score: | 4.0 |
Pubmed(PMID): | 35447220 |
Sentence Index: | 35447220_10-11 |
Sentence: | "In addition, the ERK1/2 phosphorylation increased leading to osteosarcoma cell death since pre-treatment with the MEK inhibitor PD98059 had reverted QUE effect. Altogether, these results indicate that low concentrations of QUE stimulate osteoblastogenesis but have no effect on the growth of tumor osteoblast cells, for which only high concentrations are efficient." |
Sequence & Structure:
MAGRGKLIAVIGDEDTVTGFLLGGIGELNKNRHPNFLVVEKDTTINEIEDTFRQFLNRDDIGIILINQYIAEMVRHALDAHQRSIPAVLEIPSKEHPYDAAKDSILRRAKGMFTAEDLR
Select PDB:
No data.
Protein Tractability:
source: Open TargetsNo data.
PTM Intensity:
source: CPTACNo intensity data of this site,
show all other sites!
BAD-Ser118 | |
---|---|
Cancer | Intensity |
BRCA | 1.02 |
COAD | 0.094 |
HGSC | -2.688 |
ccRCC | 0.665 |
GBM | -0.315 |
HNSC | 0.337 |
LUAD | -0.509 |
LUSC | 0.254 |
non_ccRCC | 0.67 |
PDAC | 0.544 |
UCEC | -0.072 |
BAD-Ser134 | |
---|---|
Cancer | Intensity |
BRCA | 0.496 |
COAD | 0.025 |
HGSC | -2.571 |
ccRCC | 0.505 |
GBM | -0.168 |
HNSC | -0.14 |
LUAD | 0.142 |
LUSC | 0.308 |
non_ccRCC | 1.623 |
PDAC | 0.07 |
UCEC | -0.291 |
BAD-Ser146 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | 0.707 |
PDAC | -0.707 |
UCEC |
BAD-Ser25 | |
---|---|
Cancer | Intensity |
BRCA | 1.201 |
COAD | 0.333 |
HGSC | -2.06 |
ccRCC | 0.071 |
GBM | 0.221 |
HNSC | 0.141 |
LUAD | 0.314 |
LUSC | -0.147 |
non_ccRCC | 1.088 |
PDAC | -1.618 |
UCEC | 0.456 |
BAD-Ser32 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.634 |
HGSC | |
ccRCC | -0.649 |
GBM | -0.387 |
HNSC | -1.466 |
LUAD | 0.675 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 1.193 |
BAD-Ser34 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.402 |
HGSC | -2.657 |
ccRCC | 0.246 |
GBM | 0.244 |
HNSC | |
LUAD | 0.294 |
LUSC | 0.335 |
non_ccRCC | 0.503 |
PDAC | 0.255 |
UCEC | 0.378 |
BAD-Ser75 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.707 |
HGSC | 0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
BAD-Ser91 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | 0.707 |
ccRCC | |
GBM | -0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
BAD-Ser99 | |
---|---|
Cancer | Intensity |
BRCA | 0.402 |
COAD | -1.167 |
HGSC | 1.633 |
ccRCC | -1.772 |
GBM | -0.506 |
HNSC | -0.659 |
LUAD | -0.029 |
LUSC | 0.613 |
non_ccRCC | 0.977 |
PDAC | -0.255 |
UCEC | 0.764 |
BAD-Thr80 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.707 |
HGSC | -0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
BAD-Tyr76 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.707 |
HGSC | -0.707 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
PTM-Disease Association:
source: PTMDNo data.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.